Found 8 matching trials
JS212 Combination Therapies in Metastatic Colorectal Cancer PHASE2 This is an open-label, multicenter Phase 2 clinical study designed to evalu...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour PHASE1 This study is a Phase I/II Clinical Study to Evaluate the Safety, Tolerabil...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer PHASE2 This is a multicenter, open-label Phase II clinical study, with the main ob...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study PHASE2 This is a Phase II study evaluating the safety, tolerability, pharmacokinet...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy PHASE2 This study targets patients with advanced NSCLC driven with positive driver...
Show More Location
Guangdong Provicial People's Hospital
Learn More & Join Trial
JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC NA This is a single-arm clinical study evaluating the safety, tolerability, an...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma PHASE2 This study is an open-label, multi-center phase II clinical trial aimed to ...
Show More Location
Cancer Hospital of Chinese Academy of Medical Sciences
Learn More & Join Trial
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors PHASE2 This is a multicenter, open-label Phase II clinical study. The primary obje...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial